A plethora of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic
tests are available, each with different performance specifications, detection methods, and …

The emergence and worldwide dissemination of SARS-CoV-2 required both urgent
development of new diagnostic tests and expansion of diagnostic testing capacity on an …

The unprecedented scale of testing required to effectively control the coronavirus disease
(COVID-19) pandemic has necessitated urgent implementation of rapid testing in clinical …

The corona virus disease 2019 (COVID‐19) is a highly contagious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). More than 18 million …

The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly
implement and validate diagnostic assays and to expand testing capacity in a short …

Introduction: Since the first wave of COVID-19 in Europe, new diagnostic tools using antigen
detection and rapid molecular techniques have been developed. Our objective was to …

Diagnostic testing for SARS-CoV-2 continues to be a critical component of the pandemic
response. Numerous SARS-CoV-2 tests that provide rapid, accurate, and reliable results at …

The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
globally has relied extensively on molecular testing, contributing vitally to case identification …

Abstract The coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, SARS-
CoV-2, has infected more than 50.6 million individuals and caused over 1.2 million deaths …

COVID-19 has brought death and disease to large parts of the world. Governments must
deploy strategies to screen the population and subsequently isolate the suspect cases …